Cargando…
PD-L1 expression and patient outcomes in gastrointestinal neuroendocrine neoplasm: a meta-analysis
BACKGROUND: Programmed cell death ligand 1 (PD-L1) is a known prognostic and therapeutic marker in malignant tumors. This meta-analysis aimed to investigate the association of PD-L1 expression with the clinicopathological parameters and survival outcomes of gastrointestinal neuroendocrine neoplasms...
Autores principales: | Lee, Woojoo, Kim, Min-ju, Choi, Younghee, Kim, Hyunchul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798646/ https://www.ncbi.nlm.nih.gov/pubmed/35116539 http://dx.doi.org/10.21037/tcr-20-3482 |
Ejemplares similares
-
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020) -
Histopathology of gastrointestinal neuroendocrine neoplasms
por: Hirabayashi, Kenichi, et al.
Publicado: (2013) -
Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
por: Cavalcanti, Elisabetta, et al.
Publicado: (2017) -
Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm
por: Wang, Haixing, et al.
Publicado: (2019) -
Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update
por: Elpek, Gulsum Ozlem
Publicado: (2022)